AJP - Heart Calcium Transients and Cell-Sarcomere
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (May 22, 2009). doi:10.1152/ajpheart.00689.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
297/1/H425    most recent
00689.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Donato, A. J.
Right arrow Articles by Seals, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Donato, A. J.
Right arrow Articles by Seals, D. R.
Submitted on July 2, 2008
Revised on May 11, 2009
Accepted on May 19, 2009

Vascular Endothelial Dysfunction with Aging: Endothelin-1 and Endothelial Nitric Oxide Synthase

Anthony John Donato1*, Lindsey B Gano1, Iratxe Eskurza, Annemarie E Silver1, Phillip E Gates2, Kristen L. Jablonski1, and Douglas R. Seals3

1 University of Colorado at Boulder
2 Peninsula Medical School, University of Exeter
3 University of Colorado-Boulder

* To whom correspondence should be addressed. E-mail: tony.donato{at}colorado.edu.

It is unknown if reductions in endothelium-dependent dilation (EDD) in older adults is associated with changes in the expression of major vasoconstrictor or vasodilator proteins in the vascular endothelium. Protocol 1: Endothelial cells (EC) were obtained from peripheral veins of 50 men: 27 young (22 ± 1 years) and 23 older (62 ± 1 years). EDD (brachial artery flow-mediated dilation) was lower (3.50 ± 0.44 vs. 7.68 ± 0.43%, P<0.001) and EC endothelin-1 (ET-1) (quantitative immunofluorescence) was greater (0.47 ± 0.06 vs. 0.32 ± 0.03, P < 0.05) in the older men. Endothelial nitric oxide synthase (eNOS) was not different in the two groups (P>0.05), whereas ser1177 phosphorylated eNOS (PeNOS), an activated form of eNOS, was greater in the older men (0.82 ± 0.15 vs. 0.40 ± 0.06, P < 0.05). EDD was inversely related to EC ET-1 (r = -0.37, P < 0.05). Protocol 2: Brachial artery EC ET-1 (0.99 ± 0.10 vs. 0.57 ± 0.10, P=0.01) and PeNOS (0.77 ± 0.09 vs. 0.44 ± 0.07, P < 0.05) were greater, and EDD (peak forearm blood flow to intra-brachial acetylcholine) was lower (P<0.05) in older (10.2 ± 0.9, n = 18) vs. young (14.7 ± 1.7, n = 15) healthy men. EDD was inversely related to expression of ET-1 (r=-0.39, P < 0.05). Protocol 3: ET-1 receptor A inhibition with BQ-123 restored 60% of the age-related impairment in carotid artery dilation to acetylcholine in B6D2F1 mice (5-7 mo, n = 8; 30 mo, n = 11; P < 0.05). Conclusions: ET-1 expression is increased in ECs of older men and related to reduced EDD, whereas ET-1 receptor A signaling tonically suppresses EDD in old mice. PeNOS is increased in older men, but not eNOS. Changes in ET-1 expression and bioactivity, but not eNOS, contribute to endothelial dysfunction with aging.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.